Endoglin regulates PI3-kinase/Akt trafficking and signaling to alter endothelial capillary stability during angiogenesis

Molecular Biology of the Cell

Volumn 23, Issue 13, 2012, Pages 2412-2423

  Lee, Nam Y ^a,c   Golzio, Christelle ^b   Gatza, Catherine E ^a   Sharma, Arun ^a   Katsanis, Nicholas ^b   Blobe, Gerard C ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 9; ENDOGLIN; G ALPHA INTERACTING PROTEIN CARBOXYL TERMINUS INTERACTING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME REGULATION; HOMEOSTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ZEBRA FISH;

ANIMALS; ANTIGENS, CD; CAPILLARIES; CARRIER PROTEINS; CELL CULTURE TECHNIQUES; CELL MEMBRANE; CELLS, CULTURED; ENZYME ACTIVATION; GROWTH DIFFERENTIATION FACTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MORPHOGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; ZEBRAFISH;

DANIO RERIO;

EID: 84863535641     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-12-0993     Document Type: Article

References (42)

1. Bernabeu C, Conley BA, Vary CP (2007). Novel biochemical pathways of endoglin in vascular cell physiology. J Cell Biochem 102, 1375-1388. (Pubitemid 350223941)
2. Bourdeau A, Dumont DJ, Letarte M (1999). A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104, 1343-1351.
3. Cheifetz S, Bellon T, Cales C, Vera SC, Bernabeu C, Massague J, Letarte M (1992). Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267, 19027-19030.
4. Conley B, Koleva R, Simth J, Kacer D, Zhang D, Bernabeu C, Vary CP (2004). Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain. J Biol Chem 279, 27440-27449. (Pubitemid 38812583)
5. David L, Feige JJ, Bailly S (2009). Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20, 203-212.
6. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S (2007). Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109, 1953-1961. (Pubitemid 46348192)
7. Davis GE, Koh W, Stratman AN (2007). Mechanisms controlling human endothelial lumen formation and tube assembly in three-dimensional extracellular matrices. Birth Defects Res C Embryo Today 81, 270-285. (Pubitemid 351186175)
8. Derynck R, Zhang YE (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584. (Pubitemid 37280136)
9. Fernandez LA, Sanz-Rodriguez F, Zarrabeitia R, Pérez-Molino A, Hebbel RP, Nguyen J, Bernabéu C, Botella LM (2005). Blood outgrowth endothelial cells from hereditary haemorrhagic telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res 68, 235-248. (Pubitemid 41428420)
10. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M (2003). Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 22, 6557-6563. (Pubitemid 37372335)
11. Fujita D, Tanabe A, Kamegai H, Ohmichi M (2010). Role of extracellular signal-regulated kinase and AKT cascades in regulating hypoxia-induced angiogenic factors produced by a trophoblast-derived cell line. J Endocrinol 206, 131-140.
12. Geering B, Cutillas PR, Vanhaesebroeck B (2007). Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits. Biochem Soc Trans 35, 199-203. (Pubitemid 46596467)
13. Gilbert JS, Gilbert SA, Arany M, Granger JP (2009). Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 53, 399-403.
14. Gu Y, Zhang L, Zhao X, Gao X, Ning Y, Meng A, Chen YG (2006). Functional analysis of mutations in the kinase domain of the TGF-beta receptor ALK1 reveals different mechanisms for induction of hereditary hemorrhagic telangiectasia. Blood 107, 1951-1954. (Pubitemid 43289376)
15. Hellyer NJ, Kim MS, Koland JG (2001). Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor. J Biol Chem 276, 42153-42161.
16. Jerkic M, Rodriguez-Barbero A, Prieto M, Letarte M, Lopez-Novoa JM (2006). Reduced angiogenic responses in adult endoglin heterozygous mice. Cardiovasc Res 69, 845-854. (Pubitemid 43227983)
17. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Diamond A, Jackson CE, Attisano L, Porteous ME, Marchuk DA (1996). Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13, 189-195.
18. Kontos CD, Stauffer TP, Yang WP, York JD, Huang L, Blanar MA, Meyer T, Peters KG (1998). Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 18, 4131-4140. (Pubitemid 28287936)
19. Lastres P, Letamendia A, Almendro N, Raab U, Lopez LA, Langa C, Fabra A, Letarte M, Bernabeu C (1996). Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol 133, 1109-1121. (Pubitemid 26172515)
20. Lebrin F, Goumans MJ, Jonker L, Arthur HM, ten Dijke P (2004). Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J 23, 4018-4028. (Pubitemid 39472423)
21. Lee NY, Blobe GC (2007). The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. J Biol Chem 282, 21507-21517. (Pubitemid 47099970)
22. Lee NY, Haney JC, Sogani J, Blobe GC (2009). Casein kinase 2beta as a novel enhancer of activin-like receptor-1 signaling. FASEB J 23, 3712-3721.
23. Lee NY, Ray B, How T, Blobe GC (2008). Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J Biol Chem 283, 32527-32533.
24. Li C, Hampson I N, Hampson L, Kumar P, Bernabeu C, Kumar S (2000). CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J 14, 55-64. (Pubitemid 30051523)
25. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP (1999). Defective angiogenesis in mice lacking endoglin. Science 284, 1534-1537.
26. Mahmoud M, Allinson KR, Zhai Z, Oakenfull R, Ghandi P, Adams RH, Fruttiger M, Arthur HM (2010). Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res 106, 1425-1433.
27. Marchuk DA (1998). Genetic abnormalities in hereditary hemorrhagic telangiectasia. Curr Opin Hematol 5, 332-338.
28. McAllister KA, Baldwin MA, Thukkani AK, Gallione CJ, Berg JN, Porteous ME, Guttmacher AE, Marchuk DA (1995). Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 4, 1983-1985.
29. Murata H, Hresko RC, Mueckler M (2003). Reconstitution of phosphoinositide 3-kinase-dependent insulin signaling in a cell-free system. J Biol Chem 278, 21607-21614. (Pubitemid 36792560)
30. Pardali E, Goumans MJ, ten Dijke P (2010). Signaling by members of the TGF-β family in vascular morphogenesis and disease. Trends Cell Biol 20, 556-567.
31. Park SO et al. (2008). ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111, 633-642.
32. Pece-Barbara N, Vera S, Karthirkamanthamby K, Liebner S, Di Guglielmo GM, Dejana E, Wrana JL, Letarte M (2005). Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway. J Biol Chem 280, 27800-27808. (Pubitemid 41076895)
33. Ponce ML (2009). Tube formation: an in vitro Matrigel angiogenesis assay. Methods Mol Biol 467, 183-188.
34. Roman BL, Pham VN, Lawson ND, Kulik M, Childs S, Weinstein BM (2002). Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. Development 129, 3009-3019. (Pubitemid 34874278)
35. Santibanez J, Perez-Gomez E, Vary C, Bernabeu C (2010). The TGF-β co-receptor endoglin modulates the expression and transforming potential of H-Ras. Carcinogenesis 31, 2145-2154.
36. Sanz-Rodrigues F, Guerrero-Esteo M, Botella L, Banville D, Vary C, Bernabeu C (2004). Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins. J Biol Chem 279, 32858-32868. (Pubitemid 39014746)
37. Shi Y, Massague J (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700. (Pubitemid 36724933)
38. Taniai E, Kawai M, Dewa Y, Nishimura J, Harada T, Mitsumori K, Shibutani M (2009). Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model. Cancer Sci 100, 813-820.
39. Wang L, Mukhopadhyay D, Xu X (2006). C-terminus of RGS-GAIP-interacting protein conveys neuropilin-1-mediated signaling during angiogenesis. FASEB J 20, 1513-1515.
40. Westerfield M (1995). The Zebrafish Book, Eugene: University of Oregon Press.
41. Yi JY, Shin I, Arteaga CL (2005). Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 280, 10870-10876. (Pubitemid 40395952)
42. Zaghloul NA et al. (2010). Functional analyses of variants reveal a significant role for dominant negative and common alleles in oligogenic Bardet-Biedl syndrome. Proc Natl Acad Sci USA 107, 10602-10607.